Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
3.930
+0.070 (1.81%)
At close: Oct 8, 2025, 4:00 PM EDT
3.940
+0.010 (0.25%)
After-hours: Oct 8, 2025, 4:10 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $15.50 million as of October 8, 2025. Its market cap has decreased by -6.29% in one year.
Market Cap
15.50M
Enterprise Value
-13.58M
1-Year Change
-6.29%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $15.50M, a decrease of -96.84%. That is a compound annual growth rate of -49.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 15.22M | -32.90% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |